Internal Medicine, Hematology & Oncology · Tucson, AZ
NPI
1730341850
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
603 N Wilmot Rd Ste 151
Tucson, AZ, 85711
Phone (520) 886-0206
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
159,695 services
Medicare patients, 2024
523
Average age 75
Drug cost, 2024
$2.6M
2,153 prescriptions
Company payments, 2025
$4,617
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aisha Ahmed was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 15,720 times for 11 patients. In total Aisha Ahmed billed 159,695 services in 129 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 15,720 | 11 | $0.22 | $3,437 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,225 | 20 | $45.05 | $371K |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,756 | 26 | $0.08 | $532 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,150 | 30 | $0.12 | $711 |
| J0185 Injection, aprepitant, 1 mg | Office | 5,200 | 22 | $1.35 | $7,031 |
| J9025 Injection, azacitidine, 1 mg | Office | 4,910 | 11 | $0.29 | $1,425 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2,915 | 11 | $2.34 | $6,832 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,526 | 77 | $0.09 | $137 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,300 | 11 | $15.93 | $21K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,090 | 46 | $0.24 | $263 |
| J0897 Injection, denosumab, 1 mg | Office | 960 | 14 | $20.50 | $20K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 930 | 59 | $0.67 | $627 |
| 96375 Injection Administration | Office | 481 | 108 | $11.71 | $5,635 |
| J9395 Injection, fulvestrant, 25 mg | Office | 460 | 12 | $6.08 | $2,799 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 429 | 54 | $69.22 | $30K |
By year: 2022 $2.0M for 121,868 services; 2023 $2.0M for 146,000 services; 2024 $1.7M for 159,695 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aisha Ahmed prescribed most often to Medicare patients was Letrozole, with 522 prescriptions and refills. In total Aisha Ahmed wrote 2,153 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 522 | 1,147 | 176 | $11K |
| Pantoprazole Sodium Generic | 199 | 386 | 73 | $1,726 |
| Tamoxifen Citrate Generic | 185 | 415 | 61 | $4,177 |
| Ondansetron Hcl Generic | 103 | 106 | 56 | $769 |
| Verzenio Abemaciclib | 101 | 101 | 17 | $1.5M |
| Gabapentin Generic | 77 | 120 | 24 | $673 |
| Prochlorperazine Maleate Generic | 69 | 69 | 40 | $820 |
| Citalopram Hbr Citalopram Hydrobromide | 68 | 90 | 19 | $281 |
| Olanzapine Generic | 57 | 62 | 24 | $441 |
| Duloxetine Hcl Generic | 50 | 78 | 14 | $1,406 |
| Dexamethasone Generic | 46 | 49 | 35 | $305 |
| Ursodiol Generic | 41 | 49 | Under 11 | $1,877 |
| Kisqali Ribociclib Succinate | 35 | 35 | Under 11 | $558K |
| Eliquis Apixaban | 30 | 42 | Under 11 | $24K |
| Anastrozole Generic | 30 | 85 | 11 | $605 |
Brand drugs: 222 claims; generic drugs: 1,931 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aisha Ahmed $4,617 ($4,617 in general payments such as food, travel and fees) from 23 companies. The largest payer was Daiichi Sankyo Inc. with $2,749.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 5 | $2,749 |
| Gilead Sciences, Inc. GILD | 7 | $663 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $278 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $240 |
| Celgene Corporation BMY | 6 | $121 |
| Pfizer Inc. PFE | 6 | $94.17 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $73.57 |
| GlaxoSmithKline, LLC. GSK | 3 | $71.29 |
| Abbvie Inc. ABBV | 3 | $64.18 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $55.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.